Document Detail


Drug-disease interaction in elderly patients in family practice.
MedLine Citation:
PMID:  24691059     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective: To determine the frequency of potential drug-disease interaction in elderly patients in family practice. To assess which drugs and diagnoses are associated with a high risk related to drug-disease interaction and whether there are gender- or age-related differences. Methods: In routinely recorded electronic patient records, patients at least 65 years old with at least one diagnosis named in Beers list and one prescription were identified. Potential drug-disease interaction (PDDI) was presumed if within the same 3 months a "Beers" diagnosis and a potentially inappropriate prescription with respect to this diagnosis were documented for a patient. Multiple logistic regression analysis identified factors associated with a high risk of PDDI. Results: Of 24,619 patients (63.4% women) corresponding to our inclusion criteria, 10.4% were exposed to at least one PDDI. Almost no (0.0%) PDDI was associated with the most common Beers disorder hypertension (prevalence 49.2%). However, 23.4% of men suffering from bladder outflow obstruction (prevalence 17.6% in males) were exposed to at least one PDDI. PDDI was quite common in some rarer conditions, for example, indications for anticoagulation (prevalence 2.6%, 31.5% PDDI). PDDI was not influenced by gender, but associated with taking more than 4 drugs (OR 1.91 (1.83 - 2.00)), suffering from more than one Beers disorder (OR 1.24 (1.16 - 1.31)), and advanced age (OR 1.10 (1.05 - 1.15)). Conclusions: High risk patient groups could be identified. Some disorders as well as some drugs are particularly prone to risky constellations; these should be reflected in systems assisting prescribing with regard to patient safety.
Authors:
Peter Mand; Katharina Roth; Frank Biertz; Markus Kersting; Carsten Kruschinski; Guido Schmiemann; Eva Hummers-Pradier
Related Documents :
23931979 - Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal...
23844749 - Consumer cost sharing and use of biopharmaceuticals for rheumatoid arthritis.
24521189 - Anesthetic pharmacology and perioperative considerations for the end stage liver diseas...
21549569 - Antiprotozoal compounds: state of the art and new developments.
16867699 - Development of a standardized analysis strategy for basic drugs using ion-pair extracti...
23216449 - Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-defic...
3049859 - The ocular distribution of bunolol in the eyes of albino and pigmented rabbits.
2736429 - Allergic reactions to the australian paralysis tick, ixodes holocyclus: diagnostic eval...
15830819 - Evidence for macrofilaricidal activity of ivermectin against female onchocerca volvulus...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-2
Journal Detail:
Title:  International journal of clinical pharmacology and therapeutics     Volume:  -     ISSN:  0946-1965     ISO Abbreviation:  Int J Clin Pharmacol Ther     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-4-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423309     Medline TA:  Int J Clin Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chromones as a privileged scaffold in drug discovery: A review.
Next Document:  Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chines...